MedPath

Effect of oral azithromycin three times per week on the reduction of asthma exacerbation in patients with persistent asthma

Not Applicable
Completed
Conditions
Persistent asthma
Respiratory
Asthma
Registration Number
ISRCTN14464685
Lead Sponsor
ational Institute of Diseases of the Chest and Hospital (NIDCH)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
160
Inclusion Criteria

1. Aged = 12 years
2. Persistent asthma patient

Exclusion Criteria

1. Substantial parenchymal lung disease, such as emphysema
2. Current and ex-smokers
3. Patients with hearing impairment
4. Abnormally prolonged QTc interval
5. Asthma with bronchiectasis
6. Hypersensitivity to azithromycin

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath